美股市場個股詳情
MNKD 曼恩凱德生物醫療
- 6.905
- +0.025+0.36%
交易中 11/21 15:56 (美東)
19.04億總市值86.31市盈率TTM
6.980最高價6.740最低價216.32萬股成交量6.890今開6.880昨收1483.47萬成交額0.80%換手率虧損市盈率(靜)2.76億總股本7.63052周最高-9.07市淨率18.62億流通值3.17052周最低--股息TTM2.70億流通股121.550歷史最高--股息率TTM3.49%振幅0.666歷史最低6.857平均價1股每手
關於曼恩凱德生物醫療公司
MannKind Corp是一家生物製藥公司。它致力於爲糖尿病和肺動脈高壓等疾病的患者開發吸入治療產品並將其商業化。其批准的產品Afrezza（人用胰島素）吸入粉劑是一種超速效吸入式胰島素，用於改善成年人糖尿病患者的血糖控制。該產品由小型便攜式吸入器提供的人胰島素乾粉製劑組成。
公司介紹
公司代碼MNKD
公司名稱曼恩凱德生物醫療
上市日期2004/07/28
發行價格14.00
成立日期1991
CEOMr. Michael E. Castagna, Pharm.D.
所屬市場納斯達克
員工數量414
年結日12-31
公司地址1 Casper Street
城市Danbury
省份康涅狄格州
國家美國
郵編06810
電話1-818-661-5000
董事高管
- 姓名
- 職務
- 年薪
- Michael E. Castagna, Pharm.D.
- Director and Chief Executive Officer
- 706.81萬
- Christopher B. Prentiss
- Chief Financial Officer and Principal Accounting Officer
- --
- Stuart A. Tross, PhD
- Executive Vice President, Chief People and Workplace Officer
- 222.03萬
- Dr. Burkhard Blank,M.D.
- Executive Vice President, Research and Development and Chief Medical Officer
- --
- Lauren M. Sabella
- Executive Vice President and Chief Operating Officer
- 190.63萬
- Dr. David B. Thon, J.D.
- Executive Vice President, General Counsel and Secretary
- 234.30萬
- Sanjay R. Singh
- Executive Vice President, Technical Operations
- --
- Dr. James S. Shannon, M.D.,M.R.C.P.
- Chairman of the Board
- 25.56萬
- Steven B. Binder
- Director
- 233.51萬
- Christine A. Mundkur
- Independent Director
- 22.67萬
- Anthony C. Hooper
- Independent Director
- 23.31萬
- Jennifer Grancio
- Independent Director
- 22.17萬
- Ronald J. Consiglio
- Independent Director
- 24.17萬
- Sabrina Kay
- Independent Director
- 22.17萬
- Dr. Michael A. Friedman M.D.
- Independent Director
- 22.92萬
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據